Synthetic Biologics, Inc. License Agreements
10 Contracts & Agreements
- License Agreement between Bellvitge Biomedical Research Institute Foundation (Idibell) and VCN Biosciences S.L. dated May 4, 2016 (Filed With SEC on March 16, 2022)
- Contract to Grant Marketing License for Catalan Institute of Oncology Patent Ownership Application to VCN Biosciences S.L (Filed With SEC on March 16, 2022)
- Fourth Amendment to Exclusive License Agreement entered into February 16, 2017 between Synthetic Biologics, Inc. and Cedars-Sinai Medical Center (Filed With SEC on February 22, 2018)
- SIXTH AMENDMENT TO THE LICENSE AGREEMENT UC Control No. 2006-04-0026 (Filed With SEC on July 9, 2015)
- FIFTH AMENDMENT TO THE LICENSE AGREEMENT UC Control No. 2006-04-0026 (Filed With SEC on July 9, 2015)
- FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 31, 2014)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 10, 2013)
- Second Amendment to the License AgreementBetween the Regents of the University of California and General Fiber, Inc. License Agreement Control No. 2006-04-0026 EffectiveJanuary 3,... (Filed With SEC on April 16, 2013)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on April 16, 2013)
- SECONDAMENDMENT TO LICENSE AGREEMENT (Filed With SEC on June 26, 2009)
